Virksomhedens formål er at udvikle produkter og ydelser til behandling af leversygdomme samt enhvervirksomhed i hermed stående forbindelse
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 3.7 mio. | 516 t. | 4.2 mio. | 1.1 mio. | 4 | |
CVR: 42280909
Secondary names: LT Health ApS
Previous names: LT Health ApS
Compared to 998 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Lars Dahl Allerup joined the board
Kristian Villumsen joined the board
Jens Kristian Damsgaard left the board
Maja Sofie Thiele left the board
Companies in the same industry and area
CVR 45950263
CVR 46350782
CVR 46090772
CVR 36003871
CVR 45876829
companydata.dk